Meet Symphony: Your Partner in Advanced Health Benefits
For over two decades, Symphony’s parent company INTERLINK® has led the way in enhancing patient outcomes by integrating local care with national Centers of Excellence. Our journey began with complex transplants and expanded to pioneering cancer treatments. We empower members with access to cutting-edge clinical trials and treatments, ensuring top-tier care both locally and nationally.
Our Goal
At Symphony, our purpose is to support the physical and emotional health of our clients and their loved ones through innovative treatments and dedicated care, transforming their journey towards recovery.
Our Purpose
We aim to make high-cost medical conditions manageable and treatable by providing our clients with the essential information, support, and resources they need to survive and thrive.
Who we are
Leaders in Transplant, Cancer, ESRD, and Gene & Cell Therapy Solutions
Specialties: Abdominal Transplant Surgeon, Oncologic Surgeon
Specialties: Bone Marrow Transplant, Cellular Transplant, Hematology, Medical Oncology
Specialties: program Architect, Oncology (Medical, Surgical, and Radiologic), Transplantation, Gene & Cellular Therapy, Case Management, Leadership
Specialties: Chief Strategist, Healthcare Management
Specialties: ERISA/Benefit Plan Language, Contracting, Negotiating, Healthcare Operations
Specialties: Certified Nurse Executive, Oncology, NCCN Guideline Trainer, Case Management, Certified Medical-Surgical Nursing
Kevin brings a deep background in successfully growing investor-backed, innovative healthcare companies. Prior to Renalogic, he was president of population health for a technology company, Azara Healthcare. Previously he has served as CEO and in other executive positions at a variety of pioneering healthcare companies including Allscripts (NASDAQ: MDRX), ZirMed (now Waystar), and Valence Health (now part of Evolent Health (NYSE: EVH). Kevin joined Renalogic in 2021 and serves on the company’s board of directors.
Mark joined Renalogic in 2018, bringing with him over 23 years of diversified healthcare experience that includes operations, sales & marketing, product development, mergers and acquisitions. His academic credentials include earning a B.A. and master of business administration. As president, Mark leads Renalogic’s product and process teams, which include quality, strategy, IT and data, cost containment and care management programs.
